[go: up one dir, main page]

SG126792A1 - Matrix tablet enabling the prolonged release of trimetazidine after administration by the oral route - Google Patents

Matrix tablet enabling the prolonged release of trimetazidine after administration by the oral route

Info

Publication number
SG126792A1
SG126792A1 SG200502569A SG200502569A SG126792A1 SG 126792 A1 SG126792 A1 SG 126792A1 SG 200502569 A SG200502569 A SG 200502569A SG 200502569 A SG200502569 A SG 200502569A SG 126792 A1 SG126792 A1 SG 126792A1
Authority
SG
Singapore
Prior art keywords
trimetazidine
administration
oral route
prolonged release
matrix tablet
Prior art date
Application number
SG200502569A
Inventor
De Bruno Huet Barochez
Claude Dauphant
Patrick Wuthrich
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Priority to SG200502569A priority Critical patent/SG126792A1/en
Publication of SG126792A1 publication Critical patent/SG126792A1/en

Links

SG200502569A 2005-04-27 2005-04-27 Matrix tablet enabling the prolonged release of trimetazidine after administration by the oral route SG126792A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG200502569A SG126792A1 (en) 2005-04-27 2005-04-27 Matrix tablet enabling the prolonged release of trimetazidine after administration by the oral route

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG200502569A SG126792A1 (en) 2005-04-27 2005-04-27 Matrix tablet enabling the prolonged release of trimetazidine after administration by the oral route

Publications (1)

Publication Number Publication Date
SG126792A1 true SG126792A1 (en) 2006-11-29

Family

ID=38288517

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200502569A SG126792A1 (en) 2005-04-27 2005-04-27 Matrix tablet enabling the prolonged release of trimetazidine after administration by the oral route

Country Status (1)

Country Link
SG (1) SG126792A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1108424A1 (en) * 1999-12-17 2001-06-20 Adir Et Compagnie Matrix tablet for sustained release of trimetazidine after oral administration
EP1195160A1 (en) * 2000-10-05 2002-04-10 USV Ltd. Sustained release trimetazidine pharmaceutical compositions and a method of their preparation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1108424A1 (en) * 1999-12-17 2001-06-20 Adir Et Compagnie Matrix tablet for sustained release of trimetazidine after oral administration
EP1195160A1 (en) * 2000-10-05 2002-04-10 USV Ltd. Sustained release trimetazidine pharmaceutical compositions and a method of their preparation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
A FLEXIBLE TECHNOLOGY FOR MODIFIED RELEASE OF DRUGS: MULTI LAYER *
BIOAVAILABILITY STUDIES ON GUAR GUM- BASED THREE-LAYER MATRIX TABLETS OF TRIMETAZIDINE DIHYDROCHLORIDE IN HUMAN VOLUNTEERS *

Similar Documents

Publication Publication Date Title
ZA200705530B (en) Sustained release pharmaceutical formulations
IL177566A0 (en) Pharmaceutical formulations
IL187475A0 (en) Oral dosage form comprising an antimisuse system
GB0426301D0 (en) Pharmaceutical formulations
EP1976489A4 (en) Multiple unit type sustained release oral formulation and process for the preparation thereof
ZA200810164B (en) Sustained release pharmaceutical dosage form containing phenylphrine
IL182964A0 (en) Gabapentin prodrug sustained release oral dosage forms
HRP20130498T1 (en) Solid matrix pharmaceutical preparation
IL189631A0 (en) A controlled release pharmaceutical composition containing hypromellose
EP1757273A4 (en) Preparation for oral administration
PL1957073T3 (en) Medicinal drug
IL201465A0 (en) Self-precipitating pharmaceutical formulations for the modified release of active principle
EP1923074A4 (en) Orally disintegratable tablet
EP1895991A4 (en) Modified release formulations of anti-irritability drugs
HUP0500803A2 (en) Sustained release pharmaceutical preparation containing carvedilol
EP1802346A4 (en) Sustained release pharmaceutical composition
GB0416397D0 (en) Pharmaceutical formulations
GB0423800D0 (en) New pharmaceutical formulations
EP1753405A4 (en) Controlled release pharmaceutical formulation
IL198160A0 (en) Pharmaceutical formulations
ZA200707910B (en) Contraceptive pharmaceutical preparation
EP1871348A4 (en) Sustained release pharmaceutical compositions
GB0406048D0 (en) Drug formulations
EP1915988A4 (en) Tablet having multiple drug-containing segments
SG126792A1 (en) Matrix tablet enabling the prolonged release of trimetazidine after administration by the oral route